Showing 2181-2190 of 4174 results for "".
Miliary Osteoma Cutis: An Unusual, Sudden-Onset Presentation of a Rare Eruption; Call for Cases
https://practicaldermatology.com/youngmd-connect/resident-resource-center/miliary-osteoma-cutis-an-unusual-sudden-onset-presentationof-a-rare-eruption-call-for-cases/23067/Claim to Fame: When Celebrities Come Forward with Health Conditions, Patients Pay Attention
https://practicaldermatology.com/topics/practice-management/claim-to-fame-when-celebrities-come-forward-with-health-conditions-patients-pay-attention/23751/Lance Bass shared news about his PsA diagnosis, which may improve awareness.Physician Spotlight: Peter van de Kerkhof, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-peter-van-de-kerkhof-md-phd/23431/Therapeutics Focus: Psoriasis
https://practicaldermatology.com/topics/practice-management/therapeutics-focus-psoriasis/21106/New products and pharmacologic developments#In-Review: Two New Melanoma Agents Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/in-review-two-new-melanoma-agents-approved/21534/Utilizing genetic abnormalities, new therapies are carving out new possibilities for melanoma treatment.Melanoma and the Predictive Value of Nevi: Unexpected Findings?
https://practicaldermatology.com/topics/practice-management/melanoma-and-the-predictive-value-of-nevi-unexpected-findings/20936/A new analysis shows that the association between nevi and melanoma is complex.Therapeutics Focus: Fungal Infections
https://practicaldermatology.com/topics/practice-management/therapeutics-focus-fungal-infections/21184/The Melanoma Pipeline
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-melanoma-pipeline/21400/A closer look at the latest data for two investigational agents that have made headlines.Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.The Importance of Patient-Reported Outcomes in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/the-importance-of-patient-reported-outcomes-in-atopic-dermatitis/85435/Patient-reported outcomes provide valuable information on nonvisible symptoms, quality of life, and disease control from the patient’s perspective.